This report provides a comprehensive analysis of the global In Vitro Diagnostic (IVD) labware market, examining its trajectory through 2030. Driven by rising diagnostic testing needs and the expansion of healthcare infrastructure, the market is segmented by product type, application, and end user. Plastic labware and molecular diagnostics are projected to experience significant growth, while the Asia Pacific region is expected to emerge as the fastest-growing market. The study offers strategic insights into key players, competitive landscapes, and evolving technological trends.

Market Overview

The IVD labware market is valued at approximately USD 3.77 billion in 2025 and is projected to reach USD 5.04 billion by 2030, growing at a CAGR of 6.0% during the forecast period.

Market Growth Drivers

The market is witnessing strong growth due to several key factors:

• Steady rise in diagnostic testing needs.
• Increasing emphasis on reliable sample handling.
• Broader expansion of laboratory services across clinical laboratories and hospitals.
• Growing awareness of early disease detection.
• The need for consistent, high-quality testing workflows.

Market Segmentation

By Product Type

• Plastic Labware: Projected to register the highest CAGR during the forecast period. In 2024, this segment recorded the highest growth due to its versatility across a wide range of diagnostic workflows, durability, consistent manufacturing quality, and compatibility with single-use testing formats. As testing volumes increase and workflows become more standardized, plastic labware remains the preferred choice.
• Glass Labware
• Other IVD Labware Products

By Application

• Molecular Diagnostics: Projected to register the highest growth during the forecasted period, driven by the growing adoption of advanced diagnostic technologies, increasing demand for early and accurate disease detection, and the expanding use of molecular tests in infectious disease and other diagnostic areas.
• Immunoassays
• Clinical Chemistry
• Hematology
• Microbiology
• Other Applications

By End User

• Clinical Laboratories
• Hospitals
• Academic Institutes
• Other End Users

By Type

• Single-use Labware
• Reusable Labware

Regional Analysis

Asia Pacific

Asia Pacific is the fastest-growing region in the IVD labware market and is expected to witness the highest growth during the forecast period. Growth is driven by:

• Rapid economic development in emerging economies.
• Rising disposable incomes.
• Increased healthcare spending across a larger population base.
• Growing prevalence of acute and chronic diseases.
• Ongoing modernization of healthcare infrastructure.
• Wider adoption of advanced diagnostic technologies, especially in semi-urban and rural areas.

Other Regions

• North America
• Europe
• Latin America
• Middle East & Africa

Competitive Landscape

Primary Participant Profile Break-up

• By Company Type:
• Tier 1: 40%
• Tier 2: 30%
• Tier 3: 30%
• By Designation:
• C-level Executives: 28%
• Director-level Executives: 15%
• Others: 57%
• By Region:
• North America: 51%
• Europe: 21%
• Asia Pacific: 18%
• Latin America: 6%
• Middle East & Africa: 4%

Key Players

• Abbott Laboratories (US)
• Accumax Lab Devices Pvt Ltd (India)
• Advantor, Inc. (US)
• Azenta, Inc. (US)
• BeingBio (US)
• bioMérieux (France)
• Brand Group (Germany)
• Corning Incorporated (US)
• Eppendorf SE (Germany)
• GENAXY SCIENTIFIC PVT. LTD (India)
• Greiner AG (Austria)
• Labcon North America (US)
• KANGJIAN Medical Apparatus Co. (China)
• QIAGEN N.V. (Netherlands)
• Sartorius AG (Germany)
• SARSTEDT AG & Co. KG (Germany)
• SCG Packaging Public Company Limited (Thailand)
• Sysmex Corporation (Japan)
• Tarsons Products Ltd. (India)
• Thermo Fisher Scientific Inc. (US)
• Wuxi NEST Biotechnology Co., Ltd. (China)
• Zhejiang Bioland Biotechnology Co., LTD (China)
• Abdos Group (India)
• Heathrow Scientific (US)
• BioVest Scientific (US)

Research Coverage & Insights

Scope of Research

This report provides a comprehensive analysis of the IVD labware market, covering:

• Market Dynamics: Detailed information on drivers, restraints, opportunities, and challenges.
• Industry Player Analysis: Business overviews, solutions, key strategies (including partnerships, collaborations, expansions, and agreements), new product launches, and recent developments.
• Competitive Ecosystem: Analysis of upcoming startups within the market.

Strategic Insights

• Market Drivers: Rising volume of diagnostic testing for chronic & infectious diseases, technological advancements in laboratories, expansion of diagnostic laboratories and healthcare infrastructure, and growing demand for advanced labware materials.
• Opportunities: Growing demand for sustainable and eco-friendly consumables and growth potential of emerging markets.
• Restraints: High cost of advanced labware and environmental sustainability concerns.
• Challenges: Need for regulatory compliance and lack of awareness and skills for advanced consumables.
• Product Development/Innovation: Insights into upcoming technologies, R&D activities, and new product launches.
• Market Development: Analysis of lucrative markets across varied regions.
• Market Diversification: Information regarding new products, untapped geographies, recent developments, and investments.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players including Thermo Fisher Scientific Inc. (US), Greiner AG (Austria), Avantor, Inc. (US), Corning Incorporated (US), and Eppendorf SE (Germany).

Reasons to Buy This Report

• Revenue Approximations: Provides closest approximations of revenue numbers for the overall market and its subsegments to assist market leaders and new entrants.
• Strategic Planning: Helps stakeholders understand the competitive landscape to better position businesses and plan go-to-market strategies.
• Market Intelligence: Provides an understanding of the "pulse of the market," including key drivers, restraints, opportunities, and challenges.

• 1 INTRODUCTION 37

  • 1.1 STUDY OBJECTIVES 37

  • 1.2 MARKET DEFINITION 37

  • 1.3 STUDY SCOPE 38

    • 1.3.1 MARKETS COVERED & REGIONAL SCOPE 38

    • 1.3.2 INCLUSIONS & EXCLUSIONS 39

    • 1.3.3 YEARS CONSIDERED 40

    • 1.3.4 CURRENCY CONSIDERED 40

  • 1.4 KEY STAKEHOLDERS 41

• 2 RESEARCH METHODOLOGY 42

  • 2.1 RESEARCH DATA 42

  • 2.2 RESEARCH APPROACH 42

    • 2.2.1 SECONDARY DATA 43

      • 2.2.1.1 Key secondary sources 43
      • 2.2.1.2 Key data from secondary sources 44

    • 2.2.2 PRIMARY DATA 45

      • 2.2.2.1 Primary sources 45
      • 2.2.2.2 Key data from primary sources 46
      • 2.2.2.3 Key industry insights 47
      • 2.2.2.4 Breakdown of primary interviews 48

  • 2.3 MARKET SIZE ESTIMATION 48

    • 2.3.1 BOTTOM-UP APPROACH 49

      • 2.3.1.1 Approach 1: Company revenue estimation approach 49
      • 2.3.1.2 Approach 2: Presentations of companies and primary interviews 50
      • 2.3.1.3 Growth forecast 50
      • 2.3.1.4 CAGR projections 50

    • 2.3.2 TOP-DOWN APPROACH 51

  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION 52

  • 2.5 MARKET SHARE ASSESSMENT 53

  • 2.6 RESEARCH ASSUMPTIONS 53

    • 2.6.1 PARAMETRIC ASSUMPTIONS 53

  • 2.7 RESEARCH LIMITATIONS 53

  • 2.8 RISK ASSESSMENT 54

• 3 EXECUTIVE SUMMARY 55

  • 3.1 KEY INSIGHTS & MARKET HIGHLIGHTS 55

  • 3.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS & STRATEGIC DEVELOPMENTS 56

  • 3.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 56

  • 3.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 57

  • 3.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 58

• 4 PREMIUM INSIGHTS 59

  • 4.1 IVD LABWARE MARKET OVERVIEW 59

  • 4.2 IVD LABWARE MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 60

  • 4.3 IVD LABWARE MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 60

  • 4.4 IVD LABWARE MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 61

  • 4.5 IVD LABWARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 61

  • 4.6 IVD LABWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 62

• 5 MARKET OVERVIEW 63

  • 5.1 INTRODUCTION 63

  • 5.2 MARKET DYNAMICS 63

    • 5.2.1 DRIVERS 64

      • 5.2.1.1 Rising volume of diagnostic testing for chronic & infectious diseases 64
      • 5.2.1.2 Technological advancements in laboratories 64
      • 5.2.1.3 Expansion of diagnostic laboratories and healthcare infrastructure 65
      • 5.2.1.4 Growing demand for advanced labware materials 66

    • 5.2.2 RESTRAINTS 66

      • 5.2.2.1 High cost of advanced labware 66
      • 5.2.2.2 Environmental sustainability concerns 67

    • 5.2.3 OPPORTUNITIES 67

      • 5.2.3.1 Growing demand for sustainable and eco-friendly consumables 67
      • 5.2.3.2 Growth potential of emerging markets 68

    • 5.2.4 CHALLENGES 68

      • 5.2.4.1 Need for regulatory compliance 68
      • 5.2.4.2 Lack of awareness and skills for advanced consumables 69

  • 5.3 UNMET NEEDS & WHITE SPACES 70

    • 5.3.1 UNMET NEEDS IN IVD LABWARE MARKET 70

    • 5.3.2 WHITE SPACE OPPORTUNITIES 70

  • 5.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 71

    • 5.4.1 INTERCONNECTED MARKETS 71

    • 5.4.2 CROSS-SECTOR OPPORTUNITIES 71

  • 5.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 72

    • 5.5.1 KEY MOVES AND STRATEGIC FOCUS 72

• 6 INDUSTRY TRENDS 73

  • 6.1 PORTER’S FIVE FORCES ANALYSIS 73

    • 6.1.1 THREAT OF NEW ENTRANTS 74

    • 6.1.2 THREAT OF SUBSTITUTES 74

    • 6.1.3 BARGAINING POWER OF BUYERS 74

    • 6.1.4 BARGAINING POWER OF SUPPLIERS 74

    • 6.1.5 INTENSITY OF COMPETITIVE RIVALRY 75

  • 6.2 MACROECONOMIC INDICATORS 75

    • 6.2.1 INTRODUCTION 75

    • 6.2.2 GDP TRENDS AND FORECAST 75

  • 6.3 SUPPLY CHAIN ANALYSIS 78

  • 6.4 VALUE CHAIN ANALYSIS 79

  • 6.5 ECOSYSTEM ANALYSIS 81

    • 6.5.1 IVD LABWARE MARKET: ROLE OF COMPANIES IN ECOSYSTEM 81

  • 6.6 PRICING ANALYSIS 82

    • 6.6.1 AVERAGE SELLING PRICE TREND OF IVD LABWARE, BY PRODUCT

    • 6.6.2 AVERAGE SELLING PRICE TREND OF PLASTIC LABWARE

    • 6.6.3 AVERAGE SELLING PRICE TREND OF IVD LABWARE PRODUCTS

  • 6.7 TRADE ANALYSIS 85

    • 6.7.1 IMPORT SCENARIO (HS CODE 7017) 85

    • 6.7.2 EXPORT SCENARIO (HS CODE 7017) 86

  • 6.8 KEY CONFERENCES & EVENTS, 2025-2026 86

  • 6.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 87

  • 6.10 INVESTMENT & FUNDING SCENARIO 88

  • 6.11 CASE STUDY ANALYSIS 88

    • 6.11.1 CASE STUDY 1: IMPLEMENTATION OF CUSTOMIZED PIPETTING SYSTEM IN A MOLECULAR DIAGNOSTIC WORKFLOW 88

    • 6.11.2 CASE STUDY 2: QUANTITATIVE COMPETITIVE PCR ASSAY FOR HIV-1 USING A MICROPLATE-BASED DETECTION APPROACH 89

    • 6.11.3 CASE STUDY 3: MICROFLUIDIC PCR TUBE INTEGRATION FOR ON-TUBE PURIFICATION AND AMPLIFICATION 89

  • 6.12 IMPACT OF 2025 US TARIFFS ON IVD LABWARE MARKET 90

    • 6.12.1 INTRODUCTION 90

    • 6.12.2 KEY TARIFF RATES 90

    • 6.12.3 PRICE IMPACT ANALYSIS 91

    • 6.12.4 KEY IMPACT ON COUNTRY/REGION 91

      • 6.12.4.1 North America 91
      • 6.12.4.2 Europe 91
      • 6.12.4.3 Asia Pacific 92

    • 6.12.5 IMPACT ON END-USE INDUSTRIES 92

      • 6.12.5.1 Hospitals 92
      • 6.12.5.2 Clinical laboratories 92

• 7 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 93

  • 7.1 KEY EMERGING TECHNOLOGIES 93

    • 7.1.1 IMMUNOASSAYS 93

    • 7.1.2 MOLECULAR DIAGNOSTICS 93

    • 7.1.3 CLINICAL CHEMISTRY 93

    • 7.1.4 MICROBIOLOGY 94

  • 7.2 COMPLEMENTARY TECHNOLOGIES 94

    • 7.2.1 MICROFLUIDICS AND LAB-ON-A-CHIP PLATFORMS 94

  • 7.3 TECHNOLOGY/PRODUCT ROADMAP 94

    • 7.3.1 SHORT TERM (2025-2027) | PROCESS IMPROVEMENT & STANDARDIZATION 95

      • 7.3.1.1 Focus areas: 95
        • 7.3.1.1.1 Material development 95
        • 7.3.1.1.2 Product innovations 95
        • 7.3.1.1.3 Market adoption 95

    • 7.3.2 MID TERM (2027-2030) | MATERIAL DIVERSIFICATION & SUSTAINABILITY 95

      • 7.3.2.1 Focus areas: 95
        • 7.3.2.1.1 Material development 95
        • 7.3.2.1.2 Product innovations 95
        • 7.3.2.1.3 Market adoption 95

    • 7.3.3 LONG TERM (2030-2035+) | HIGH-PERFORMANCE & ECO-EFFICIENT LABWARE 96

      • 7.3.3.1 Focus areas: 96
        • 7.3.3.1.1 Material development 96
        • 7.3.3.1.2 Product innovations 96
        • 7.3.3.1.3 Market adoption 96

  • 7.4 PATENT ANALYSIS 97

    • 7.4.1 LIST OF MAJOR PATENTS 98

  • 7.5 FUTURE APPLICATIONS 99

  • 7.6 IMPACT OF AI/GENERATIVE AI ON IVD LABWARE MARKET 99

    • 7.6.1 INTRODUCTION 99

    • 7.6.2 TOP USE CASES & MARKET POTENTIAL 100

    • 7.6.3 AI USE CASES 100

    • 7.6.4 IMPLEMENTATION OF AI, BY KEY COMPANY AND USE CASE 101

    • 7.6.5 FUTURE OF AI IN IVD LABWARE MARKET 102

• 8 SUSTAINABILITY AND REGULATORY LANDSCAPE 103

  • 8.1 REGIONAL REGULATIONS AND COMPLIANCE 103

    • 8.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES

    • 8.1.2 INDUSTRY STANDARDS 105

  • 8.2 SUSTAINABILITY INITIATIVES 106

    • 8.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN IVD LABWARE 106

      • 8.2.1.1 Eco-friendly Initiatives 106

  • 8.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 107

  • 8.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 107

• 9 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 109

  • 9.1 DECISION-MAKING PROCESS 109

  • 9.2 KEY STAKEHOLDERS & BUYING EVALUATION CRITERIA 109

    • 9.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 109

    • 9.2.2 BUYING CRITERIA 110

  • 9.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 111

  • 9.4 UNMET NEEDS IN VARIOUS END-USER INDUSTRIES 112

  • 9.5 MARKET PROFITABILITY 112

    • 9.5.1 REVENUE POTENTIAL 112

    • 9.5.2 COST DYNAMICS 113

    • 9.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 113

• 10 IVD LABWARE MARKET, BY PRODUCT 114

  • 10.1 INTRODUCTION 115

  • 10.2 PLASTIC LABWARE 115

    • 10.2.1 TUBES 118

      • 10.2.1.1 Centrifuge/Microcentrifuge tubes 121
        • 10.2.1.1.1 Growing demand for molecular and biochemical testing to drive adoption 121
      • 10.2.1.2 PCR tubes 124
        • 10.2.1.2.1 Growing adoption of molecular diagnostics to boost demand for PCR tubes 124
      • 10.2.1.3 Cryovials/Storage vials 126
        • 10.2.1.3.1 Rising need for secure sample preservation to support demand 126
      • 10.2.1.4 Culture tubes 129
        • 10.2.1.4.1 Rising focus on efficient sample cultivation to fuel demand 129
      • 10.2.1.5 Other tubes 132

    • 10.2.2 PLATES 134

      • 10.2.2.1 Microplates 137
        • 10.2.2.1.1 Automation and standardization to support use of microplates 137
      • 10.2.2.2 PCR plates 140
        • 10.2.2.2.1 Rising incidence of infectious diseases to drive demand for PCR plates 140
      • 10.2.2.3 Deep-well plates for sample preparation/extraction 143
        • 10.2.2.3.1 Growing demand for high-throughput and automated sample handling to support growth 143
      • 10.2.2.4 Cell culture plates 146
        • 10.2.2.4.1 Increasing adoption of cell-based diagnostic methods to drive demand 146
      • 10.2.2.5 Other plates 148
        • 10.2.2.5.1 Increasing adoption of cell-based diagnostic methods to drive demand 148

    • 10.2.3 PIPETTES 151

      • 10.2.3.1 Rising emphasis on accuracy in liquid handling to boost market demand 151

    • 10.2.4 PETRI DISHES & CUVETTES 154

      • 10.2.4.1 Growing incidence of infectious diseases and metabolic disorders to fuel adoption 154

    • 10.2.5 OTHER PLASTIC LABWARE PRODUCTS 157

  • 10.3 GLASS LABWARE 159

    • 10.3.1 TEST TUBES 162

      • 10.3.1.1 Rising need for contamination-free sample handling to

    • 10.3.2 BEAKERS & FLASKS 165

      • 10.3.2.1 Increased need for precise reagent preparation in diagnostics to drive adoption 165

    • 10.3.3 VIALS 167

      • 10.3.3.1 Rising focus on maintaining sample purity to boost demand 167

    • 10.3.4 PETRI DISHES & CUVETTES 170

      • 10.3.4.1 Increasing demand for precision and contamination control to support market growth 170

    • 10.3.5 SLIDES & COVERSLIPS 172

      • 10.3.5.1 Expanding use of microscopy in diagnostics to fuel adoption 172

    • 10.3.6 OTHER GLASS LABWARE PRODUCTS 175

  • 10.4 OTHER IVD LABWARE PRODUCTS 177

• 11 IVD LABWARE MARKET, BY TYPE 180

  • 11.1 INTRODUCTION 181

  • 11.2 SINGLE-USE LABWARE 181

    • 11.2.1 NEED FOR EFFECTIVE INFECTION CONTROL AND PREVENTION OF CROSS-CONTAMINATION TO SUPPORT DEMAND 181

  • 11.3 REUSABLE LABWARE 184

    • 11.3.1 RISING INCIDENCE OF CHRONIC DISEASES TO PROVIDE OPPORTUNITIES FOR MARKET GROWTH 184

• 12 IVD LABWARE MARKET, BY APPLICATION 187

  • 12.1 INTRODUCTION 188

  • 12.2 IMMUNOASSAYS 188

    • 12.2.1 EXPANDING USE OF IVD LABWARE IN IMMUNOASSAY TESTING TO SUPPORT MARKET GROWTH 188

  • 12.3 CLINICAL CHEMISTRY 191

    • 12.3.1 RISING INCIDENCE OF CHRONIC DISEASES TO PROVIDE OPPORTUNITIES FOR MARKET GROWTH 191

  • 12.4 MOLECULAR DIAGNOSTICS 194

    • 12.4.1 GROWING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE DEMAND 194

  • 12.5 HEMATOLOGY 196

    • 12.5.1 INCREASING INCIDENCE OF BLOOD DISORDERS TO DRIVE ADOPTION OF IVD LABWARE 196

  • 12.6 MICROBIOLOGY 199

    • 12.6.1 INCREASING ADOPTION OF AUTOMATED CLINICAL MICROBIOLOGY TESTING INSTRUMENTS TO SUPPORT MARKET GROWTH 199

  • 12.7 OTHER APPLICATIONS 202

• 13 IVD LABWARE MARKET, BY END USER 205

  • 13.1 INTRODUCTION 206

  • 13.2 HOSPITALS 206

    • 13.2.1 LARGE VOLUME OF IVD TESTS PERFORMED TO SUPPORT MARKET GROWTH 206

  • 13.3 CLINICAL LABORATORIES 209

    • 13.3.1 EXPANDING DIAGNOSTIC WORKLOAD TO DRIVE LABWARE DEMAND 209

  • 13.4 ACADEMIC INSTITUTES 212

    • 13.4.1 EMPHASIS ON DIAGNOSTIC TRAINING IN ACADEMIC INSTITUTES TO BOOST MARKET GROWTH 212

  • 13.5 OTHER END USERS 214

• 14 IVD LABWARE MARKET, BY REGION 217

  • 14.1 INTRODUCTION 218

  • 14.2 NORTH AMERICA 218

    • 14.2.1 US 223

      • 14.2.1.1 Presence of advanced healthcare infrastructure and high healthcare expenditures to drive the market 223

    • 14.2.2 CANADA 227

      • 14.2.2.1 Rising government initiatives to propel market growth 227

  • 14.3 EUROPE 231

    • 14.3.1 GERMANY 235

      • 14.3.1.1 Increasing healthcare expenditure to drive market growth in Germany 235

    • 14.3.2 UK 238

      • 14.3.2.1 Growing number of accredited diagnostic & hospital laboratories to propel market 238

    • 14.3.3 FRANCE 242

      • 14.3.3.1 Increasing demand for early diagnosis to augment market growth 242

    • 14.3.4 ITALY 246

      • 14.3.4.1 Increased adoption of advanced diagnostic technologies and growing government healthcare investment to drive market 246

    • 14.3.5 SPAIN 250

      • 14.3.5.1 Growing disease burden and national initiatives to drive expansion of market 250

    • 14.3.6 REST OF EUROPE 253

  • 14.4 ASIA PACIFIC 257

    • 14.4.1 CHINA 261

      • 14.4.1.1 Growing access to modern healthcare to boost market growth 261

    • 14.4.2 JAPAN 265

      • 14.4.2.1 Well-developed healthcare system to drive market 265

    • 14.4.3 INDIA 269

      • 14.4.3.1 Expanding healthcare access and rising disease prevalence to drive market growth 269

    • 14.4.4 REST OF ASIA PACIFIC 273

  • 14.5 LATIN AMERICA 277

    • 14.5.1 BRAZIL 281

      • 14.5.1.1 Universal healthcare access to drive adoption in Brazil 281

    • 14.5.2 MEXICO 285

      • 14.5.2.1 Improved access to healthcare to drive uptake of advanced diagnostic products 285

    • 14.5.3 REST OF LATIN AMERICA 288

  • 14.6 MIDDLE EAST & AFRICA 292

    • 14.6.1 SAUDI ARABIA 296

      • 14.6.1.1 Rising government healthcare expenditure to boost market 296

    • 14.6.2 UAE 300

      • 14.6.2.1 Improvements in healthcare infrastructure to support growth 300

    • 14.6.3 REST OF MIDDLE EAST & AFRICA 303

• 15 IVD LABWARE MARKET: VOLUME ANALYSIS 308

  • 15.1 INTRODUCTION 308

    • 15.1.1 US: TOTAL NUMBER OF IVD TESTS CONDUCTED, 2023-2030 (MILLION) 308

• 16 COMPETITIVE LANDSCAPE 309

  • 16.1 INTRODUCTION 309

  • 16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 309

    • 16.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN IVD LABWARE MARKET 309

  • 16.3 REVENUE ANALYSIS, 2020-2024 311

  • 16.4 MARKET SHARE ANALYSIS, 2024 312

    • 16.4.1 GLOBAL MARKET SHARE ANALYSIS, 2024 312

    • 16.4.2 US MARKET SHARE ANALYSIS, 2024 314

  • 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 314

    • 16.5.1 STARS 315

    • 16.5.2 EMERGING LEADERS 315

    • 16.5.3 PERVASIVE PLAYERS 315

    • 16.5.4 PARTICIPANTS 315

    • 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 317

      • 16.5.5.1 Company footprint 317
      • 16.5.5.2 Region footprint 318
      • 16.5.5.3 Product footprint 319
      • 16.5.5.4 Type footprint 319
      • 16.5.5.5 Application footprint 320

  • 16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 320

    • 16.6.1 PROGRESSIVE COMPANIES 320

    • 16.6.2 RESPONSIVE COMPANIES 321

    • 16.6.3 DYNAMIC COMPANIES 321

    • 16.6.4 STARTING BLOCKS 321

    • 16.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 322

      • 16.6.5.1 Detailed list of key startups/SMEs 322
      • 16.6.5.2 Competitive benchmarking of startups/SMEs (1/2) 322
      • 16.6.5.3 Competitive benchmarking of startups/SMEs (2/2) 323

  • 16.7 COMPANY VALUATION & FINANCIAL METRICS 323

    • 16.7.1 FINANCIAL METRICS 323

    • 16.7.2 COMPANY VALUATION 324

  • 16.8 BRAND/PRODUCT COMPARISON 324

  • 16.9 COMPETITIVE SCENARIO 325

    • 16.9.1 PRODUCT LAUNCHES & APPROVALS 325

    • 16.9.2 DEALS 325

    • 16.9.3 EXPANSIONS 326

• 17 COMPANY PROFILES 328

  • 17.1 KEY PLAYERS 328

    • 17.1.1 THERMO FISHER SCIENTIFIC INC 328

      • 17.1.1.1 Business overview 328
      • 17.1.1.2 Products offered 329
      • 17.1.1.3 Recent developments 332
        • 17.1.1.3.1 Deals 332
        • 17.1.1.3.2 Expansions 333
      • 17.1.1.4 MnM view 333
        • 17.1.1.4.1 Key strengths 333
        • 17.1.1.4.2 Strategic choices 333
        • 17.1.1.4.3 Weaknesses & competitive threats 334

    • 17.1.2 GREINER AG 335

      • 17.1.2.1 Business overview 335
      • 17.1.2.2 Products offered 336
      • 17.1.2.3 Recent developments 337
        • 17.1.2.3.1 Product approvals 337
      • 17.1.2.4 MnM view 337
        • 17.1.2.4.1 Key strengths 337
        • 17.1.2.4.2 Strategic choices 337
        • 17.1.2.4.3 Weaknesses & competitive threats 337

    • 17.1.3 AVANTOR, INC 338

      • 17.1.3.1 Business overview 338
      • 17.1.3.2 Products offered 339
      • 17.1.3.3 Recent developments 340
        • 17.1.3.3.1 Deals 340
        • 17.1.3.3.2 Expansions 341
      • 17.1.3.4 MnM view 341
        • 17.1.3.4.1 Key strengths 341
        • 17.1.3.4.2 Strategic choices 341
        • 17.1.3.4.3 Weaknesses & competitive threats 341

    • 17.1.4 CORNING INCORPORATED 342

      • 17.1.4.1 Business overview 342
      • 17.1.4.2 Products offered 343
      • 17.1.4.3 Recent developments 344
        • 17.1.4.3.1 Deals 344
      • 17.1.4.4 MnM view 345
        • 17.1.4.4.1 Key strengths 345
        • 17.1.4.4.2 Strategic choices 345
        • 17.1.4.4.3 Weaknesses & competitive threats 345

    • 17.1.5 EPPENDORF SE 346

      • 17.1.5.1 Business overview 346
      • 17.1.5.2 Products offered 347
      • 17.1.5.3 Recent developments 348
        • 17.1.5.3.1 Product launches & approvals 348
        • 17.1.5.3.2 Deals 349
        • 17.1.5.3.3 Expansions 349
      • 17.1.5.4 MnM view 350
        • 17.1.5.4.1 Key strengths 350
        • 17.1.5.4.2 Strategic choices 350
        • 17.1.5.4.3 Weaknesses & competitive threats 350

    • 17.1.6 TARSONS PRODUCTS LIMITED 351

      • 17.1.6.1 Business overview 351
      • 17.1.6.2 Products offered 352

    • 17.1.7 SARTORIUS AG 353

      • 17.1.7.1 Business overview 353
      • 17.1.7.2 Products offered 354
      • 17.1.7.3 Recent developments 355
        • 17.1.7.3.1 Expansions 355

    • 17.1.8 SARSTEDT AG & CO. KG 356

      • 17.1.8.1 Business overview 356
      • 17.1.8.2 Products offered 356

    • 17.1.9 ABBOTT LABORATORIES 358

      • 17.1.9.1 Business overview 358
      • 17.1.9.2 Products offered 359
      • 17.1.9.3 Recent developments 360
        • 17.1.9.3.1 Deals 360

    • 17.1.10 BIOMÉRIEUX 361

      • 17.1.10.1 Business overview 361
      • 17.1.10.2 Products offered 362

    • 17.1.11 QIAGEN N.V 363

      • 17.1.11.1 Business overview 363
      • 17.1.11.2 Products offered 364
      • 17.1.11.3 Recent developments 365
        • 17.1.11.3.1 Expansions 365

    • 17.1.12 SYSMEX CORPORATION 366

      • 17.1.12.1 Business overview 366
      • 17.1.12.2 Products offered 367
      • 17.1.12.3 Recent developments 368
        • 17.1.12.3.1 Expansions 368

    • 17.1.13 SCG PACKAGING PUBLIC COMPANY LIMITED 369

      • 17.1.13.1 Business overview 369
      • 17.1.13.2 Products offered 370
      • 17.1.13.3 Recent developments 371
        • 17.1.13.3.1 Deals 371

  • 17.2 OTHER PLAYERS 372

    • 17.2.1 AZENTA, INC 372

    • 17.2.2 BRAND GROUP 373

    • 17.2.3 GENAXY SCIENTIFIC PVT. LTD 374

    • 17.2.4 LABCON NORTH AMERICA 375

    • 17.2.5 ACCUMAX LAB DEVICES PVT. LTD 376

    • 17.2.6 ZHEJIANG BIOLAND BIOTECHNOLOGY CO., LTD 377

    • 17.2.7 ABDOS GROUP 378

    • 17.2.8 BEINGBIO 379

    • 17.2.9 WUXI NEST BIOTECHNOLOGY CO., LTD 380

    • 17.2.10 BIOLYST SCIENTIFIC 381

    • 17.2.11 HEATHROW SCIENTIFIC 382

    • 17.2.12 KANGJIAN MEDICAL APPARATUS CO 383

• 18 APPENDIX 384

  • 18.1 DISCUSSION GUIDE 384

  • 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 389

  • 18.3 CUSTOMIZATION OPTIONS 391

  • 18.4 RELATED REPORTS 391

  • 18.5 AUTHOR DETAILS 392